Cargando…
Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9
Balancer chromosomes are convenient tools used to maintain lethal mutations in heterozygotes. We established a method for engineering new balancers in C. elegans by using the CRISPR/Cas9 system in a non-homologous end-joining mutant. Our studies will make it easier for researchers to maintain lethal...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030659/ https://www.ncbi.nlm.nih.gov/pubmed/27650892 http://dx.doi.org/10.1038/srep33840 |
_version_ | 1782454718408163328 |
---|---|
author | Iwata, Satoru Yoshina, Sawako Suehiro, Yuji Hori, Sayaka Mitani, Shohei |
author_facet | Iwata, Satoru Yoshina, Sawako Suehiro, Yuji Hori, Sayaka Mitani, Shohei |
author_sort | Iwata, Satoru |
collection | PubMed |
description | Balancer chromosomes are convenient tools used to maintain lethal mutations in heterozygotes. We established a method for engineering new balancers in C. elegans by using the CRISPR/Cas9 system in a non-homologous end-joining mutant. Our studies will make it easier for researchers to maintain lethal mutations and should provide a path for the development of a system that generates rearrangements at specific sites of interest to model and analyse the mechanisms of action of genes. |
format | Online Article Text |
id | pubmed-5030659 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50306592016-09-26 Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9 Iwata, Satoru Yoshina, Sawako Suehiro, Yuji Hori, Sayaka Mitani, Shohei Sci Rep Article Balancer chromosomes are convenient tools used to maintain lethal mutations in heterozygotes. We established a method for engineering new balancers in C. elegans by using the CRISPR/Cas9 system in a non-homologous end-joining mutant. Our studies will make it easier for researchers to maintain lethal mutations and should provide a path for the development of a system that generates rearrangements at specific sites of interest to model and analyse the mechanisms of action of genes. Nature Publishing Group 2016-09-21 /pmc/articles/PMC5030659/ /pubmed/27650892 http://dx.doi.org/10.1038/srep33840 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Iwata, Satoru Yoshina, Sawako Suehiro, Yuji Hori, Sayaka Mitani, Shohei Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9 |
title | Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9 |
title_full | Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9 |
title_fullStr | Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9 |
title_full_unstemmed | Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9 |
title_short | Engineering new balancer chromosomes in C. elegans via CRISPR/Cas9 |
title_sort | engineering new balancer chromosomes in c. elegans via crispr/cas9 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030659/ https://www.ncbi.nlm.nih.gov/pubmed/27650892 http://dx.doi.org/10.1038/srep33840 |
work_keys_str_mv | AT iwatasatoru engineeringnewbalancerchromosomesincelegansviacrisprcas9 AT yoshinasawako engineeringnewbalancerchromosomesincelegansviacrisprcas9 AT suehiroyuji engineeringnewbalancerchromosomesincelegansviacrisprcas9 AT horisayaka engineeringnewbalancerchromosomesincelegansviacrisprcas9 AT mitanishohei engineeringnewbalancerchromosomesincelegansviacrisprcas9 |